US$ 22.68
tirzepatide on medicaid House panel gives GLP-1 drug coverage for adults Medicaid a thumbs down Medicaid adds weight-loss drug coverage
Description
Articolo a cura di Roberto Eusebio

Drawing 9 units delivers 2.7mg

It works by mimicking the action of incretin hormones, which enhance insulin secretion in response to meals, suppress glucagon release, slow gastric emptying, and reduce appetite

Tirzepatide dosing ranges from 2.5 mg to 15 mg weekly

About 4% of patients discontinue tirzepatide due to intolerable side effects
Reduced joint pain and medication use Large-scale analysis has found that patients using tirzepatide are significantly less likely to develop osteoarthritis than those on other weight-loss medications